Tobias R Kollmann

Title: Innovations of Tobias R Kollmann

Introduction

Tobias R Kollmann is an accomplished inventor based in the Bronx, NY. He has made significant contributions to the field of immunology, particularly through his innovative work on chimeric mice. With a total of 2 patents, his inventions are paving the way for advancements in vaccine development and immune response research.

Latest Patents

Kollmann's latest patents focus on the creation of a chimeric mouse capable of mounting both murine cellular and humoral immune responses. This chimeric mouse is designed to be tolerant of human tissue implanted within it. The invention allows for the development of murine T cells and the production of murine IgG antibodies that are also tolerant of the human tissue. This unique capability enables researchers to challenge the vaccinated mouse with human-specific pathogens, thereby assessing the vaccine's effectiveness in protecting the implanted tissue from infection. Additionally, the patent outlines a method for developing this chimeric mouse and its application in screening vaccines for human-specific pathogens.

Career Highlights

Kollmann is affiliated with the Albert Einstein College of Medicine, where he continues to push the boundaries of immunological research. His work has garnered attention for its potential to revolutionize how vaccines are tested and developed, particularly in relation to human diseases.

Collaborations

Kollmann collaborates with Harris Goldstein, a fellow researcher, to further enhance the impact of their work in the field of immunology.

Conclusion

Tobias R Kollmann's innovative contributions to the development of chimeric mice represent a significant advancement in immunology. His work not only enhances our understanding of immune responses but also holds promise for the future of vaccine development.